Viewing Study NCT02719132


Ignite Creation Date: 2025-12-24 @ 9:25 PM
Ignite Modification Date: 2026-02-19 @ 8:17 AM
Study NCT ID: NCT02719132
Status: WITHDRAWN
Last Update Posted: 2016-05-20
First Post: 2016-03-21
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Effect of DapagliFLOzin on Quality of Life in Patients With Type 2 Diabetes in a Real Clinical PrActice
Sponsor: AstraZeneca
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2016-07
Start Date Type: None
Primary Completion Date: 2017-11
Primary Completion Date Type: ESTIMATED
Completion Date: 2017-11
Completion Date Type: ESTIMATED
First Submit Date: 2016-03-21
First Submit QC Date: None
Study First Post Date: 2016-03-25
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2016-05-19
Last Update Post Date: 2016-05-20
Last Update Post Date Type: ESTIMATED